Trial intelligence / Profile preview

Lidocaine techniques for postoperative sore throat in thoracic surgery

NCT06705595Completed

Sponsor
American Hospital
Start
Nov 2024
Primary completion
Dec 2024
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial of lidocaine 10% oropharyngeal spray in postoperative sore throat (POST) (3 arms), sponsored by American Hospital. Primary endpoint: Postoperative Sore Throat at 24 hours. Started Nov 2024; status: completed.

02

Drugs

lidocaine 10% oropharyngeal spray
03

Conditions

postoperative sore throat (POST)

Beyond the preview

Go deeper on NCT06705595.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06705595.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call